Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Concise Synthesis of Fostriecin and Analogs through Late-Stage Chemoenzymatic Installation of Their Key Pharmacophores

Open access
Jiang, Yanlong, Yu, Xuerong, Renata, Hans·2025·Journal of the American Chemical Society

Published version of a preprint

Abstract

As one of the most potent and selective protein phosphatase inhibitors, fostriecin shows a broad range of anticancer activity. In light of fostriecin’s antiproliferative properties, a phase I clinical trial was conducted on the natural product, but was soon halted due to issues with compound stability and purity. Numerous efforts in the past two decades have yielded 17 successful syntheses that proceed in 19 to 34 steps. Herein, we develop a modular chemoenzymatic approach that provides fostriecin and its analogs in a collective manner in 9 steps (longest linear sequence). The synthesis features a convergent assembly of three key fragments and a late-stage chemoenzymatic derivatization of an advanced intermediate that (i) installs two of the key pharmacophores and (ii) allows ready diversification of the hydrophobic tail. A key feature in this derivatization is the optimization of an enzymatic C–H oxidation step through the concurrent use of decoy molecule strategy and rational enzyme engineering. Cumulatively, our strategy capitalizes on the exquisite chemoselectivity of enzymatic transformations while ensuring synthetic modularity and versatility for analog generation. This work will facilitate future investigation into the biological activities and medicinal chemistry of the natural product family.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/jacs.5c05269

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Research works printed but not linked: 3

  1. Cheng A., 1998, Cancer Res., 58, 3611
  2. Roberge M., 1994, Cancer Res., 54, 6115
  3. 10.1002/1099-0690(200210)2002:20<3455::AID-EJOC3455>3.0.CO;2-V · doi:10.1002/1099-0690(200210)2002:20<3455::aid-ejoc3455>3.0.co;2-v

Metadata

Authors
Jiang, Y., Yu, X., & Renata, H.
Affiliations
  • Peking University (CN)
  • Rice University (US)
Corresponding author
Renata, Hans
Venue
Journal of the American Chemical Society
Published
2025-07-09
Volume
147
Issue
29
Pages
25454-25461
ISSN
  • 0002-7863 (ISSN-L)
  • 1520-5126
OpenAlex
W4412119354
Cited by
5
References
50
Citations by year
2026: 4 · 2025: 1
FWCI
1.50
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Chemical Society (publishedVersion)
  • ChemRxiv (acceptedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
Funders
  • Alfred P. Sloan Foundation
  • Cancer Prevention and Research Institute of Texas (RR220087)
  • National Institute of General Medical Sciences (R35GM128895)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Enzyme Catalysis and Immobilization
  • Physical Sciences › Chemistry › Organic Chemistry › Organophosphorus compounds synthesis
  • Physical Sciences › Chemistry › Organic Chemistry › Asymmetric Synthesis and Catalysis
Keywords
fostriecin, chemoenzymatic synthesis, late-stage functionalization, protein phosphatase inhibitors, anticancer agents, rational enzyme design, convergent synthesis, natural product synthesis
MeSH terms
Enzyme Inhibitors, Molecular Structure

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Concise Synthesis of Fostriecin and Analogs through Late-Stage Chemoenzymatic Installation of Their Key Pharmacophores. https://app.cochat.ai/papers/10.1021/jacs.5c05269
The paper
Jiang, Y., Yu, X., & Renata, H. (2025). Concise Synthesis of Fostriecin and Analogs through Late-Stage Chemoenzymatic Installation of Their Key Pharmacophores. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c05269

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.